Kuykendall, A. T., Jain, T., Singh, A., Pettit, K. M., Sallman, D. A., Mo, Q., Zhang, L., Chan, O., Walker, A. R., Xie, Z., Lancet, J. E., Balasis, M., Yun, S., Padron, E., Komrokji, R. S. (2026). A phase 2 study of fedratinib in patients with MDS/MPN and chronic neutrophilic leukemia.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6509